The rise and fall of pneumococcal serotypes carried in the PCV era

Vanessa T. Devine(University of Southampton), Stuart C. Clarke(University Hospital Southampton NHS Foundation Trust), Rebecca Anderson(University of Southampton), Andrew Tuck(University of Southampton), Rebecca A. Gladstone(Wellcome Sanger Institute), Denise E. Morris(University Hospital Southampton NHS Foundation Trust), Grace O'Doherty(University of Southampton), Saul N. Faust(University Hospital Southampton NHS Foundation Trust), Stephen D. Bentley(Wellcome Sanger Institute), David Cleary(University of Birmingham), Priyasharmila Kuruparan(University of Southampton), Johanna M. Jefferies(University Hospital Southampton NHS Foundation Trust)
Vaccine
February 2, 2017
10.1016/j.vaccine.2017.01.035
Cited by 77

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18
|Nature|2001|1.3k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children
|Pediatric Critical Care Medicine|2020|1.2k